Overview
Filament Health Corp. is a biotechnology company based in Canada, specializing in the development of natural psychedelic medicines. The firm focuses on extracting and refining psychoactive compounds found in plants and fungi, aiming to offer therapeutic solutions that are both effective and safe for clinical use. Key projects include advancing patent-pending extraction and standardization technologies specifically tailored for psilocybin, the active compound found in psychedelic mushrooms. Filament Health Corp. is committed to rigorous scientific processes and has initiated clinical trials to ensure their formulations meet stringent health and safety standards. Through these endeavors, the company strives to unlock new treatment options for mental health conditions, capitalizing on the therapeutic potential of psychedelics while navigating the complex regulatory landscape.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Filament Health Corp. as of June 30, 2025 is 0.47 MM.
- The operating income for Filament Health Corp. as of June 30, 2025 is -3.34 MM.
- The net income for Filament Health Corp. as of June 30, 2025 is -4.44 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 0.47 | -3.34 | -4.44 |
| 2025-03-31 | 0.42 | -3.81 | -4.91 |
| 2024-12-31 | 0.62 | -3.77 | -4.97 |
| 2024-09-30 | 2.16 | -3.43 | -4.15 |
| 2024-06-30 | 2.48 | -3.66 | -4.48 |
| 2024-03-31 | 2.43 | -4.09 | -4.98 |
| 2023-12-31 | 2.13 | -4.51 | -5.32 |
| 2023-09-30 | 0.57 | -4.82 | -16.23 |
| 2023-06-30 | 0.26 | -4.80 | -16.18 |
| 2023-03-31 | 0.36 | -4.80 | -16.13 |
| 2022-12-31 | 0.36 | -5.22 | -16.47 |
| 2022-09-30 | 0.19 | -6.21 | -6.69 |
| 2022-06-30 | 0.16 | -6.71 | -7.09 |
| 2022-03-31 | -6.87 | -8.85 | |
| 2021-12-31 | -7.27 | -9.25 | |
| 2021-09-30 | -5.15 | -7.05 | |
| 2020-12-31 | -0.19 | -0.19 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | -0.02 | -0.02 |
| 2024-06-30 | -0.02 | -0.02 |
| 2024-03-31 | -0.03 | -0.03 |
| 2023-12-31 | -0.03 | |
| 2023-09-30 | -0.09 | -0.09 |
| 2023-06-30 | -0.09 | -0.09 |
| 2023-03-31 | -0.09 | -0.09 |
| 2022-12-31 | -0.10 | |
| 2022-09-30 | -0.04 | -0.04 |
| 2022-06-30 | -0.04 | -0.04 |
| 2022-03-31 | -0.05 | -0.05 |
| 2021-12-31 | -0.06 | |
| 2021-09-30 | -0.06 | -0.06 |
| 2020-12-31 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Filament Health Corp. as of June 30, 2025 is -1.45 MM.
- The cash from investing activities for Filament Health Corp. as of June 30, 2025 is -0.01 MM.
- The cash from financing activities for Filament Health Corp. as of June 30, 2025 is 0.81 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -1.45 | -0.01 | 0.81 |
| 2025-03-31 | -1.56 | -0.03 | 0.85 |
| 2024-12-31 | -2.29 | -0.05 | 0.90 |
| 2024-09-30 | -3.03 | -0.05 | 1.76 |
| 2024-06-30 | -4.01 | -0.08 | 4.26 |
| 2024-03-31 | -4.37 | -0.07 | 3.27 |
| 2023-12-31 | -4.19 | -0.06 | 3.23 |
| 2023-09-30 | -3.69 | -0.07 | 2.43 |
| 2023-06-30 | -3.63 | -0.07 | 1.86 |
| 2023-03-31 | -3.67 | -0.07 | 2.13 |
| 2022-12-31 | -3.93 | -0.07 | 2.21 |
| 2022-09-30 | -5.03 | -0.04 | 2.16 |
| 2022-06-30 | -3.49 | -1.53 | 0.18 |
| 2022-03-31 | -6.01 | -0.03 | 4.54 |
| 2021-12-31 | -5.41 | -0.27 | 9.42 |
| 2021-09-30 | -3.67 | -0.28 | 10.62 |
| 2020-12-31 | -0.08 | 1.58 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2020-12-31 |
Management Effectiveness
- The roa for Filament Health Corp. as of June 30, 2025 is -1.04.
- The roe for Filament Health Corp. as of June 30, 2025 is -1.39.
- The roic for Filament Health Corp. as of June 30, 2025 is -4.09.
- The croic for Filament Health Corp. as of June 30, 2025 is -0.62.
- The ocroic for Filament Health Corp. as of June 30, 2025 is -1.30.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | -1.04 | -1.39 | -4.09 | -0.62 | -1.30 |
| 2025-03-31 | -0.93 | -2.65 | -1.49 | -0.47 | -1.08 |
| 2024-12-31 | -0.74 | -1.99 | -1.49 | -0.47 | -1.08 |
| 2024-09-30 | -0.78 | -1.66 | -0.96 | 0.04 | -0.86 |
| 2024-06-30 | -0.92 | -2.37 | -1.48 | -0.35 | -1.30 |
| 2024-03-31 | -3.42 | -1.67 | -4.17 | -0.34 | -0.94 |
| 2023-12-31 | -0.98 | -1.10 | -4.17 | -0.34 | -0.94 |
| 2023-09-30 | -1.02 | -1.11 | -6.75 | -0.77 | -1.15 |
| 2023-06-30 | -1.01 | -1.11 | -6.94 | -0.79 | -1.18 |
| 2023-03-31 | -0.40 | -1.04 | -4.41 | -0.44 | -1.00 |
| 2022-12-31 | -0.34 | -0.36 | -0.40 | -0.18 | -0.30 |
| 2022-09-30 | -0.36 | -0.36 | -0.43 | -0.19 | -0.32 |
| 2022-06-30 | -0.43 | -0.36 | -0.46 | -0.31 | -0.23 |
| 2022-03-31 | -10.87 | -0.54 | -0.09 | -0.37 | |
| 2021-12-31 | -11.37 | -0.53 | 0.21 | 0.00 | |
| 2021-09-30 | 0.00 | 0.34 | 0.00 | ||
| 2020-12-31 |
Gross Margins
- The gross margin for Filament Health Corp. as of June 30, 2025 is 1.00.
- The net margin for Filament Health Corp. as of June 30, 2025 is -11.63.
- The operating margin for Filament Health Corp. as of June 30, 2025 is -9.01.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 1.00 | -11.63 | -9.01 |
| 2025-03-31 | 1.00 | -1.92 | -1.59 |
| 2024-12-31 | 1.00 | -1.92 | -1.59 |
| 2024-09-30 | 1.00 | -1.81 | -1.48 |
| 2024-06-30 | 1.00 | -2.05 | -1.68 |
| 2024-03-31 | 1.00 | -28.48 | -8.45 |
| 2023-12-31 | 1.00 | -28.48 | -8.45 |
| 2023-09-30 | 1.00 | -61.17 | -18.16 |
| 2023-06-30 | 1.00 | -61.17 | -18.16 |
| 2023-03-31 | 1.00 | -44.24 | -13.17 |
| 2022-12-31 | 1.00 | -34.40 | -31.94 |
| 2022-09-30 | 1.00 | -34.40 | -31.94 |
| 2022-06-30 | -43.64 | -41.29 | |
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2020-12-31 |
Identifiers and Descriptors
| Central Index Key (CIK) |
